Anti-Migraine Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Anti-Migraine Drugs Market size was valued at USD 1.7 billion in 2017 and is expected to exhibit a CAGR of 18% during the forecast period 2021-2027.  

A migraine is a severe headache that occurs in the half of the head and lasts from 3 hours to 3 days. Symptoms include vomiting, nausea, and sensitivity to light sounds or smells. Antimigraine drugs are used to reduce the effectiveness or intensity of migraines. These antimigraines include drugs used to treat acute migraine symptoms and prevent migraine attacks. Globally, around 15% of people suffer from migraines and the increasing use of anti-migraine medications is driving the market during the forecast period.

Market Segments

By Drug Type: Triptans and Ergots

By End-users: Male and Female

By Distribution channel: Pharmaceutical stores, online stores and others

Key Players

Some of the key players in the market are Pfizer, GlaxoSmithKline, Allergan, Amgen, Eli Lilly, Teva Pharma, Biohaven Pharma, Johnson & Johnson, and Valeant Pharma. 

Scope of the Report

The research study analyzes the global Anti-Migraine Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Anti-Migraine Drugs Market Report

1. What was the Anti-Migraine Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Anti-Migraine Drugs Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Anti-Migraine Drugs Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.